A sequential methodology for integral evaluation of motor and non-motor behaviors in parkinsonian rodents

An animal model, suitable for resembling Parkinson's disease (PD) progress, should show both, motor and non-motor alterations. However, these features have been scarcely evaluated or developed in parkinsonian models induced by neurotoxins. This protocol provides modifications to original methods, allowing six different motor and non-motor behavior tests, which adequately and timely emulate the main parkinsonian sensorimotor alterations in the rat or mouse: (1) bilateral sensorimotor alterations, examined by the vibrissae test; (2) balance and motor coordination, evaluated by the uncoordinated gait test; (3) locomotor asymmetry, analyzed by the cylinder test; (4) bradykinesia, as a locomotor alteration evidenced by the open field test; (5) depressive-like behavior, judged by the forced swimming test; and (6) hyposmia, assessed by the olfactory asymmetry test. Some advantages of using these behavioral tests over others include:• No sophisticated materials or equipment are required for their application and evaluation.• They are used in rodent models for parkinsonian research, but they can also be helpful for studying other movement disorders.• These tests can accurately discriminate the affected side from the healthy one, after unilateral injury of one hemisphere, resulting in sensorimotor, olfactory or locomotor asymmetry.

[1]  C. Shaw,et al.  The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease , 2015, PloS one.

[2]  H. Rauvala,et al.  Long‐term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences , 2004, Genes, brain, and behavior.

[3]  C. Cunha,et al.  Behavioral, Neurochemical and Histological Alterations Promoted by Bilateral Intranigral Rotenone Administration: A New Approach for an Old Neurotoxin , 2011, Neurotoxicity Research.

[4]  Stephen B. Dunnett,et al.  The Corridor Task: A simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum , 2005, Brain Research Bulletin.

[5]  Nicola Simola,et al.  The 6-Hydroxydopamine model of parkinson’s disease , 2007, Neurotoxicity Research.

[6]  P. Dombrowski,et al.  Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  D. Slattery,et al.  Using the rat forced swim test to assess antidepressant-like activity in rodents , 2012, Nature Protocols.

[8]  Luis O. Soto-Rojas,et al.  A single intranigral administration of β-sitosterol β-d-glucoside elicits bilateral sensorimotor and non-motor alterations in the rat , 2020, Behavioural Brain Research.

[9]  G. Nikkhah,et al.  Subthalamic nucleus lesion improves cell survival and functional recovery following dopaminergic cell transplantation in parkinsonian rats , 2014, The European journal of neuroscience.

[10]  Colin Camerer,et al.  Adam Smith, Behavioral Economist , 2005 .

[11]  M. Moreno,et al.  Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion , 2017, PloS one.

[12]  D. Slattery,et al.  GABAB Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-Dependent , 2005, Journal of Pharmacology and Experimental Therapeutics.

[13]  Manuel A Fernandez-Parrilla,et al.  Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide , 2018, Journal of immunology research.

[14]  T. Padel,et al.  A partial lesion model of Parkinson's disease in mice – Characterization of a 6-OHDA-induced medial forebrain bundle lesion , 2015, Behavioural Brain Research.

[15]  Matthias Endres,et al.  Assessing Post-Stroke Behavior in Mouse Models of Focal Ischemia , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  C. Shaw,et al.  Chronic Exposure to Dietary Sterol Glucosides is Neurotoxic to Motor Neurons and Induces an ALS–PDC Phenotype , 2008, NeuroMolecular Medicine.

[17]  J. Armendáriz-Borunda,et al.  Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson’s disease , 2015, Journal of Biomedical Science.

[18]  D. Hernandez-Baltazar,et al.  Activation of GSK-3β and Caspase-3 Occurs in Nigral Dopamine Neurons during the Development of Apoptosis Activated by a Striatal Injection of 6-Hydroxydopamine , 2013, PloS one.

[19]  H. Carlisle,et al.  Assessment of motor balance and coordination in mice using the balance beam. , 2011, Journal of visualized experiments : JoVE.

[20]  L. Cormack,et al.  Enhanced function in the good forelimb of hemi-parkinson rats: Compensatory adaptation for contralateral postural instability? , 2008, Experimental Neurology.

[21]  K. McDowell,et al.  Environmental neurotoxin‐induced progressive model of parkinsonism in rats , 2010, Annals of neurology.

[22]  B. Stanfield,et al.  Homotopic, but not heterotopic, fetal cortical transplants can result in functional sparing following neonatal damage to the frontal cortex in rats. , 1994, Cerebral cortex.

[23]  S. Savitz,et al.  Functional assessments in the rodent stroke model , 2010, Experimental & Translational Stroke Medicine.

[24]  Joseph P Huston,et al.  Behavioral phenotyping of the MPTP mouse model of Parkinson's disease , 2001, Behavioural Brain Research.

[25]  T. Schallert,et al.  CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury , 2000, Neuropharmacology.

[26]  T. Schallert,et al.  Behavioral Tests After Intracerebral Hemorrhage in the Rat , 2002, Stroke.

[27]  Stephen B. Dunnett,et al.  Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation , 1999, The Journal of Neuroscience.